Ani Pharmaceuticals (ANIP) Change in Inventory (2012 - 2026)

Ani Pharmaceuticals has disclosed Change in Inventory across 15 years of filings, most recently posting $437000.0 for Q1 2026.

• Change in Inventory for Q1 2026 came in at $437000.0, down 30.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (down 70.04% YoY), and the FY2025 annual result was $6.0 million, down 72.0% from the prior year.
• Change in Inventory came in at $437000.0 for Q1 2026 at Ani Pharmaceuticals, up from -$3.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $11.6 million in Q2 2024 to a low of -$3.7 million in Q4 2025.
• The 5-year median for Change in Inventory is $2.3 million (2023), against an average of $3.4 million.
• Across the five-year window, Change in Inventory surged 1635.58% in 2024 and plunged 652.89% in 2025, its largest moves.
• Ani Pharmaceuticals' Change in Inventory stood at $9.5 million in 2022, then sank by 51.33% to $4.6 million in 2023, then plunged by 85.34% to $675000.0 in 2024, then slumped by 652.89% to -$3.7 million in 2025, then soared by 111.71% to $437000.0 in 2026.
• The last three Change in Inventory figures came in at $437000.0 (Q1 2026), -$3.7 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.